Skip to main content

Please select
your location below

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

By selecting the International view, you verify that you reside outside of the USA and you wish to view Diasorin's International Product Information.
This material is intended for International (non-USA) site visitors only.

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professional operators.

Simplexa® Influenza A H5N1 Direct

The detection of all H5N1 strains in nasal and nasopharyngeal swab specimens with a recent positive flu A test.

The Diasorin Molecular Simplexa® Influenza A H5N1 Direct kit is a Research Use Only (RUO) assay intended for the discrimination of all H5N1 strains in nasal and nasopharyngeal swab specimens from human patients with a recent positive flu A test. The assay supports the understanding of strain epidemiology for Research Use Only. Not for use in diagnostic procedures.

Simplexa® Influenza A H5N1 Direct

Disease state

Highly pathogenic avian influenza (HPAI) is a severe and highly contagious disease of poultry caused by avian influenza A viruses, most commonly subtypes H5 and H7, and is commonly referred to as avian or bird flu. HPAI viruses can be transmitted from wild birds to domestic poultry and may also infect other avian and animal species. Although avian influenza viruses do not typically infect humans, sporadic human infections have been reported. Importantly, the term "highly pathogenic" describes the severity of disease in birds and does not necessarily indicate increased pathogenicity in humans.

The value of Simplexa® Influenza A H5N1 Direct

Fast time-to-result

Easy-to-use sample-to-answer system with no RNA extraction required, and all-in-one reagents for use on nasal and nasopharyngeal swabs with results in 90 minutes.

Meets the needs of the evolving respiratory landscape

This RT-PCR assay enables the detection of all H5N1 strains in nasal and nasopharyngeal swab specimens from human patients with a recent positive flu A test. The assay supports the understanding of strain epidemiology for Research Use Only. Not for use in diagnostic procedures.

How Simplexa® Influenza A H5N1 Direct works

The Simplexa® Influenza A H5N1 Direct is a qualitative real-time RT-PCR assay designed for research use. It features a streamlined workflow that enables direct use of unextracted primary samples with ready-to-use PCR reagents, and runs on a reusable Direct Amplification Disc using the compact LIAISON® MDX system, offering operational simplicity, flexibility, and high-quality performance.

01

Sample-to-answer

Scan 1-8 primary unextracted samples per run, ready to use single use reaction mix vials and the 8 well Direct Amplification Disc. Simply load samples and reagents directly onto the disc, place the disc on the LIAISON® MDX Instrument and press run for results in approximately 90 minutes.

02

Intuitive LIAISON® MDX Studio Software

Integrated QC checks and reporting for individual assays or use the multi-assay suite feature for compatible assays. View PCR curves and QC charts, interface with LIS and even access software during run.

Indications for Simplexa® Influenza A H5N1 Direct use

Assay and system

A real-time RT-PCR assay run on LIAISON® MDX to enabling detection and discrimination of all H5N1 strains in nasal and nasopharyngeal swab specimens. 

Patient types

Human patients with a recent positive flu A test.

Diagnostic lab

Hospital, commercial, reference and public health laboratories.

Simplexa® Influenza A H5N1 Direct workflow

Scan, load, and go

Ready to use

  • No prep & no waste
  • Single use reagents (24 reactions)
  • No mixing, pouring, or rehydrating

Simple & easy workflow

  • No extraction needed, direct sample input
  • Liquid sensor to ensure adequate sample volume metered: no precise pipetting required
  • CLIA Moderate Complexity
01

Scan

  • Scan the assay definition QR code (upon first use only)
  • Scan the lot-specific QR code on a vial or card
  • Scan the disc barcode
  • Scan the sample barcode
02

Load

In each Disc wedge:

  • Load 50 µl of sample
  • Load 50 µl of reaction mix
  • Close the foil and remove the tab
03

Run

  • Load the disc onto the LIAISON® MDX and start the run. The results and a final report are automatically generated by the software.
  • Disc may be re-used up to 8 times (until all Wedges are utilized)

To be used on the LIAISON® MDX instrument

The LIAISON® MDX is an innovative and powerful real-time PCR instrument with two consumable disc options: the 8-well Direct Amplification Disc and the 96-well Universal Disc for higher volume testing.

Supported by an expanding menu of molecular assays, the system provides easy-to-understand results with the ability to check amplification curves after a run. All of this comes in a compact footprint measuring only 12″ by 8″ by 12″, so that it can fit into laboratories of any size.

Molecular Diagnostic Tool LIAISON® Mdx - Diasorin

LIAISON® MDX

One instrument.
Multiple discs.
Ultimate flexibility.

Discover more

Simplexa® Influenza A H5N1 Direct ordering info

Part Name
Kit Size
Registration Status
Part Number

Simplexa® Influenza A H5N1 Direct

24

RUO

MOL4370

Simplexa® Influenza A H5N1 Direct Positive Control Pack

10

RUO

MOL4380

For Research Use Only. Not for use in diagnostic procedures.

Resources

Diasorin document repository

Dialog

Luminex document repository

Discover more

Research publications

Discover more

More details about Simplexa® Influenza A H5N1 Direct

Get in touch

If you need any information about our products, contact our specialists. 

Contact us

Need any help?

Get help with Diasorin products and services.

Ask for support